Response by Agarwal et al to Letter Regarding Article, "Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo"

Stroke. 2020 Jul;51(7):e136-e137. doi: 10.1161/STROKEAHA.120.030262. Epub 2020 Jun 17.

Authors

Shashank Agarwal¹, Shadi Yaghi¹, Eva Mistry²

Affiliations

¹ Department of Neurology, New York Langone Health (S.A., S.Y.).
² Department of Neurology, Vanderbilt University Medical Center, Nashville, TN (E.M.).

PMID: 32568649
DOI: 10.1161/STROKEAHA.120.030262

No abstract available

Publication types

Letter
Comment

MeSH terms

Fibrinolytic Agents* / therapeutic use
Thrombolytic Therapy
Tissue Plasminogen Activator*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator